checkAd
    Startseite > Aktien > Fulcrum Therapeutics > Nachrichten
    Fulcrum Therapeutics Aktie
    7,5900
     
    USD
    +0,66 %
    +0,0500 USD
    Letzter Kurs 02:00:00 Nasdaq
    7,5900
     
    USD
    700 STK
    Geldkurs 08.05.24
    7,6100
     
    USD
    100 STK
    Briefkurs 08.05.24
    ISIN: US3596161097 · WKN: A2PM28 · SYM: FULC · USA

    Neueste Nachrichten

    Fulcrum Therapeutics to Participate in Upcoming May Conferences
    14:00 Uhr · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
    08.05.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8: 00 a.m. ET
    06.05.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
    28.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    22.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
    18.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    08.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
    05.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023
    27.02.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8: 00 a.m. ET
    20.02.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    06.02.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    10.11.23 · globenewswire · Fulcrum Therapeutics